These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18318455)

  • 1. Effects of lorazepam on visual perceptual abilities.
    Pompéia S; Pradella-Hallinan M; Manzano GM; Bueno OF
    Hum Psychopharmacol; 2008 Apr; 23(3):183-92. PubMed ID: 18318455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedation and memory: studies with a histamine H-1 receptor antagonist.
    Turner C; Handford AD; Nicholson AN
    J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
    Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
    Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lorazepam and oxazepam on perceptual and procedural memory functions.
    Martin J; Matthews A; Martin F; Kirkby KC; Alexander J; Daniels B
    Psychopharmacology (Berl); 2002 Nov; 164(3):262-7. PubMed ID: 12424549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorazepam impairs both visual and auditory perceptual priming.
    Vidailhet P; Danion JM; Chemin C; Kazès M
    Psychopharmacology (Berl); 1999 Dec; 147(3):266-73. PubMed ID: 10639684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers.
    Satzger W; Engel RR; Ferguson E; Kapfhammer H; Eich FX; Hippius H
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():114-9. PubMed ID: 1974070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
    de Haas SL; Franson KL; Schmitt JA; Cohen AF; Fau JB; Dubruc C; van Gerven JM
    J Psychopharmacol; 2009 Aug; 23(6):625-32. PubMed ID: 18635696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteers.
    Blin O; Simon N; Jouve E; Habib M; Gayraud D; Durand A; Bruguerolle B; Pisano P
    Clin Neuropharmacol; 2001; 24(2):71-81. PubMed ID: 11307041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability.
    Preston KL; Wolf B; Guarino JJ; Griffiths RR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):707-20. PubMed ID: 1501118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
    Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance impairment and increased anxiety resulting from the combination of alcohol and lorazepam.
    Lister RG; File SE
    J Clin Psychopharmacol; 1983 Apr; 3(2):66-71. PubMed ID: 6132935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.
    Pomara N; Tun H; DaSilva D; Hernando R; Deptula D; Greenblatt DJ
    Psychopharmacol Bull; 1998; 34(2):139-53. PubMed ID: 9640992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine-induced reduction in activity mirrors decrements in cognitive and psychomotor performance.
    Dawson J; Boyle J; Stanley N; Johnsen S; Hindmarch I; Skene DJ
    Hum Psychopharmacol; 2008 Oct; 23(7):605-13. PubMed ID: 18570226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flunitrazepam-induced changes in neurophysiological, behavioural, and subjective measures used to assess sedation.
    Lucchesi LM; Pompéia S; Manzano GM; Kohn AF; Galduroz JC; Bueno OF; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):525-33. PubMed ID: 12691789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lorazepam, sedation, and conscious recollection: a dose-response study with healthy volunteers.
    Huron C; Giersch A; Danion JM
    Int Clin Psychopharmacol; 2002 Jan; 17(1):19-26. PubMed ID: 11800502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory in humans is unaffected by central H1-antagonism, while objectively and subjectively measured sedation is increased.
    Van Ruitenbeek P; Vermeeren A; Riedel WJ
    Eur Neuropsychopharmacol; 2010 Apr; 20(4):226-35. PubMed ID: 20083393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lorazepam induces multiple disturbances in selective attention: attentional overload, decrement in target processing efficiency, and shifts in perceptual discrimination and response bias.
    Michael GA; Bacon E; Offerlin-Meyer I
    J Psychopharmacol; 2007 Sep; 21(7):691-9. PubMed ID: 17259205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem-completion tasks (indirect, direct inclusion and exclusion) are differently affected by equipotent doses of lorazepam and flunitrazepam.
    Pompéia S; Bueno OF; Galduróz JC; Tufik S
    Hum Psychopharmacol; 2003 Oct; 18(7):541-9. PubMed ID: 14533136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.